Laborie to buy Jada System from Organon for up to $465M

Medical device developer Laborie agreed to buy the Jada System, a device to treat abnormal bleeding after childbirth, from Organon for $440 million at closing plus up to $25 million contingent on 2026 revenue targets.

“Laborie agreed to buy a specialist system developed to stop bleeding for up to $465 million from Organon.”marketwatch.com

• 1 source
• marketwatch.com.Logo_svg__cls-1{fill:#3f0}Nov 7, 2025

Summarized from public sources; check the original articles before acting on it.